Ferograd 525mg/500mg Pregnancy

What is the dose of your medication?

Pregnancy of Ferograd 525mg/500mg in details

Pregnancy is always a special situation where every action or side effect of the drug varies when compared to a situation of a non-pregnant patient. It is not only because the pregnant woman's metabolism differs due to the hormonal and other changes happened to her, but also because every medicine or its metabolite passes to the baby and shows its action there. The only thing is, be cautious, attentive and well supervised when you take any single drug in pregnancy. The interactions can vary in pregnancy, and the dosage may differ as well. Strict supervision of the Physician is mandatory.

Ferograd 525mg/500mg has been assigned to pregnancy category A by the FDA. During pregnancy, Ferograd 525mg/500mg is usually used for the treatment of megaloblastic anemia. Ferograd 525mg/500mg requirements are increased during pregnancy, and deficiency may result in fetal harm. Studies involving pregnant women have failed to reveal evidence that Ferograd 525mg/500mg increases the risk of fetal abnormalities if administered during pregnancy. Ferograd 525mg/500mg should only be used during pregnancy if clearly needed.

The recommended daily allowance of Ferograd 525mg/500mg during pregnancy is 400 to 800 mcg/day. Some experts recommend daily doses of 1 mg for twin pregnancies. The Centers of Disease Control (CDC) in the US have recommended 4 mg/day of Ferograd 525mg/500mg at least 4 weeks BEFORE conception through the first 3 months of pregnancy for women who have had an infant or fetus with a neural tube defect and 400 mcg/day for all women of childbearing age. Interestingly, neonates with normal serum folate concentrations have been born to folate-deficient mothers. It appears that the fetus can extract folate from maternal plasma, convert folate to a form that is not available for reverse transfer, and use it for its own advantage. Dietary Ferograd 525mg/500mg is available from green leaves, such as asparagus, broccoli, spinach, and lettuce--each of which contains greater than 1 mg Ferograd 525mg/500mg per 100 grams dry weight. Excessive cooking can remove or destroy the food content of folate.

See references

Ferograd 525mg/500mg breastfeeding

When a drug is taken when the patient is breast feeding, a part of the drug is secreted in her breast milk and is passed to the baby. The dosage of the medicine to mother and baby are different, and many drugs actions are side effects when you take them without a disease, and what if you the baby takes them without a disease? What if the drug is contraindicated in newborns, infants or children? So, breastfeeding is a very alarming situation when the mother is on medications. Ask your Physician or Pediatrician about the effect of the drug on the baby and how much is excreted in breast milk and if it harms the baby!

In one study, lactating mothers were given 1 mg of Ferograd 525mg/500mg per day. There were significant correlations between the maternal and infant plasma and RBC folate concentrations. The average maternal plasma Ferograd 525mg/500mg concentration was 5.9 ng/mL, which correlated with an average milk Ferograd 525mg/500mg level of 141.4 ng/mL and an average infant plasma Ferograd 525mg/500mg concentration of 29 ng/mL. The calculated total intake of Ferograd 525mg/500mg by nursing infants was 14 to 25 mcg/kg/day. Colostrum is relatively low in folate, but milk folate increases as lactation proceeds. Folate levels in breast-fed infants are significantly higher than in the mothers.

Ferograd 525mg/500mg is actively excreted into human milk. No adverse effects in nursing infants have been associated with the use of Ferograd 525mg/500mg during lactation. Ferograd 525mg/500mg is considered compatible with breast-feeding by the American Academy of Pediatrics. The recommended maternal daily allowance of Ferograd 525mg/500mg during lactation is 500 mcg. Supplementation is not typically needed in mothers with good nutritional habits.

See references

References for pregnancy information

  1. Pritchard JA, Scott DE, Whalley PJ "Maternal folate deficiency and pregnancy wastage. IV. Effects of Ferograd 525mg/500mg supplements, anticonvulsants, and oral contraceptives." Am J Obstet Gynecol 109 (1971): 341-6
  2. Dawson DW "Microdoses of Ferograd 525mg/500mg in pregnancy." J Obstet Gynaecol Br Commonw 73 (1966): 44-8
  3. Swinhoe DJ, Maclean AB, Gibson BE "Iron and folate supplements during pregnancy." BMJ 298 (1989): 118-9
  4. Willett WC "Ferograd 525mg/500mg and neural tube defect: can't we come to closure?" Am J Public Health 82 (1992): 666-8
  5. Hibbard BM, Hibbard ED, Jeffcoate TN "Ferograd 525mg/500mg and reproduction." Acta Obstet Gynecol Scand 44 (1965): 375-400
  6. Rolschau J, Date J, Kristoffersen K "Ferograd 525mg/500mg supplement and intrauterine growth." Acta Obstet Gynecol Scand 58 (1979): 343-6
  7. Hibbard BM, Hibbard ED "The prophylaxis of folate deficiency in pregnancy." Acta Obstet Gynecol Scand 48 (1969): 339-48
  8. Kitay DZ "Ferograd 525mg/500mg and reproduction." Clin Obstet Gynecol 22 (1979): 809-17
  9. Horn E "Iron and folate supplements during pregnancy: supplementing everyone treats those at risk and is cost effective." BMJ 297 (1988): 1325,1327
  10. Chan A, Pickering J, Haan EA, Netting M, Burford A, Johnson A, Keane RJ "''Folate before pregnancy'': the impact on women and health professionals of a population-based health promotion campaign in South Australia." Med J Australia 174 (2001): 631-6
  11. Tamura T, Goldenberg RL, Freeberg LE, Cliver SP, Cutter GR, Hoffman HJ "Maternal serum folate and zinc concentrations and their relationships to pregnancy outcome." Am J Clin Nutr 56 (1992): 365-70
  12. Cooper BA, Cantlie GS, Brunton L "The case for Ferograd 525mg/500mg supplements during pregnancy." Am J Clin Nutr 23 (1970): 848-54
  13. Dansky LV, Rosenblatt DS, Andermann E "Mechanisms of teratogenesis: Ferograd 525mg/500mg and antiepileptic therapy." Neurology 42(4 Suppl) (1992): 32-42
  14. Lind T "Nutrient requirements during pregnancy--I." Am J Clin Nutr 34 Suppl 4 (1981): 669-78
  15. Department of Health and Human Services, Food and Drug Administration "Food labeling: health claims and label statements; folate and neural tube defects." Fed Regist 61 (1996): 8752-80
  16. Alperin JB, Haggard ME, McGanity WJ "Ferograd 525mg/500mg, pregnancy, and abruptio placentae." Am J Clin Nutr 22 (1969): 1354-61
  17. Girling JC, Shennan AH "Epilepsy and pregnancy. Emphasise the importance of extra folate." BMJ 307 (1993): 937
  18. Department of Health and Human Services, Food and Drug Administration "Food standards: amendment of standards of identity for enriched grain products to require addition of Ferograd 525mg/500mg." Fed Regist 61 (1996): 8781-97
  19. Pippard MJ, Chanarin I "Iron and folate supplements during pregnancy." BMJ 297 (1988): 1611
  20. Rush D "Periconceptional folate and neural tube defect." Am J Clin Nutr 59(2 Suppl) (1994): s511-515dic. 515-516
  21. Kitay DZ "Ferograd 525mg/500mg in pregnancy." JAMA 204 (1968): 79
  22. Rothman D "Ferograd 525mg/500mg in pregnancy." Am J Obstet Gynecol 108 (1970): 149-75
  23. Wise J "Neural tube defects decline in US after Ferograd 525mg/500mg is added to flour." Br Med J 322 (2001): 1510
  24. Hibbard BM, Hibbard ED "The treatment of folate deficiency in pregnancy." Acta Obstet Gynecol Scand 48 (1969): 349-56
  25. Berkowitz R, Coustan D, Mochizuki T. "Handbook for Prescribing Medications During Pregnancy. 2nd ed." Boston, MA: Little, Brown, and Company (1986): 242

References for breastfeeding information

  1. Tamura T, Yoshimura Y, Arakawa T "Human milk folate and folate status in lactating mothers and their infants." Am J Clin Nutr 33 (1980): 193-7
  2. O'Connor DL, Tamura T, Picciano MF "Pteroylpolyglutamates in human milk." Am J Clin Nutr 53 (1991): 930-4
  3. Jathar VS, Kamath SA, Parikh MN, Rege DV, Satoskar RS "Maternal milk and serum vitamin B12, Ferograd 525mg/500mg, and protein levels in Indian subjects." Arch Dis Child 45 (1970): 236-41
  4. Committee on Drugs, 1992 to 1993 "The transfer of drugs and other chemicals into human milk." Pediatrics 93 (1994): 137-50
  5. Cooperman JM, Lopez R "Pteroylglutamates in human milk." Am J Clin Nutr 54 (1991): 760-2
  6. Cooperman JM, Dweck HS, Newman LJ, Garbarino C, Lopez R "The folate in human milk." Am J Clin Nutr 36 (1982): 576-80
  7. Cooperman JM "Folates in human milk." Am J Clin Nutr 46 (1987): 863



  1. DailyMed. "ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE; PHYTONADIONE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5'-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A; VITAMIN E: DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).". https://dailymed.nlm.nih.gov/dailyme... (accessed September 17, 2018).
  2. PubMed Health. "Folic Acid (By injection): This section provide the link out information of drugs collectetd in PubMed Health. ". http://www.ncbi.nlm.nih.gov/pubmedhe... (accessed September 17, 2018).
  3. Human Metabolome Database (HMDB). "Folic acid: The Human Metabolome Database (HMDB) is a freely available electronic database containing detailed information about small molecule metabolites found in the human body.". http://www.hmdb.ca/metabolites/HMDB0... (accessed September 17, 2018).


Consumer reviews

There are no reviews yet. Be the first to write one!

Your name: 
Spam protection:  < Type 27 here

Information checked by Dr. Sachin Kumar, MD Pharmacology

| Privacy Policy
This site does not supply any medicines. It contains prices for information purposes only.
© 2003 - 2022 ndrugs.com All Rights Reserved